
    
      The purpose of this study is to compare the safety and tolerability of Zanamivir using a
      Rotahaler to placebo within the Rotahaler presentation and to the Diskhaler. Eighteen
      subjects will receive each of three treatments for 5 days in a 3-way crossover design.
    
  